Even though 16 of the 25 stocks in the portfolio went down in price, overall performance remained unchanged.

Nine constituents of our non-penny Pot Stock Index of 25 pure-play cannabis stocks advanced by 5% or more on Friday.

Trulieve has provided a straight-forward comparison of its Q2 performance with Q1 compared to the more common sleight-of-hand method deployed by under-performers.

Cannabis stocks are going to get their biggest catalyst yet from the presidential election in November.

The equal-weighted, pure-play non-penny Pot Stock Index (NPSI) had a remarkable day on Friday up more than any other day in the past month with two of the three associated sector categories up considerably as well. The details are as follows: